Search by Drug Name or NDC

    NDC 62135-0536-30 TELMISARTAN 40 mg/1 Details

    TELMISARTAN 40 mg/1

    TELMISARTAN is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Chartwell RX, LLC.. The primary component is TELMISARTAN.

    Product Information

    NDC 62135-0536
    Product ID 62135-536_f68d40e5-9d6f-282b-e053-2a95a90af381
    Associated GPIs
    GCN Sequence Number 040910
    GCN Sequence Number Description telmisartan TABLET 40 MG ORAL
    HIC3 A4F
    HIC3 Description ANTIHYPERTENSIVES, ANGIOTENSIN RECEPTOR ANTAGONIST
    GCN 23831
    HICL Sequence Number 018839
    HICL Sequence Number Description TELMISARTAN
    Brand/Generic Generic
    Proprietary Name TELMISARTAN
    Proprietary Name Suffix n/a
    Non-Proprietary Name TELMISARTAN
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 40
    Active Ingredient Units mg/1
    Substance Name TELMISARTAN
    Labeler Name Chartwell RX, LLC.
    Pharmaceutical Class Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA078710
    Listing Certified Through 2024-12-31

    Package

    NDC 62135-0536-30 (62135053630)

    NDC Package Code 62135-536-30
    Billing NDC 62135053630
    Package 30 TABLET in 1 BOTTLE (62135-536-30)
    Marketing Start Date 2023-03-08
    NDC Exclude Flag N
    Pricing Information N/A